Qualigen therapeutics issues ceo letter to stockholders, reports on significant progress and fiscal second quarter financial results

Carlsbad, calif., nov. 13, 2020 /prnewswire/ -- qualigen therapeutics, inc. (nasdaq: qlgn) announces that michael poirier, president, chief executive officer and chairman, has issued a letter to qualigen's stockholders. the full text is as follows: to my fellow stockholders, since our...

QLGN Ratings Summary

QLGN Quant Ranking